News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI
Dana-Farber Cancer Institute/dana-farber.org
Nov 26, 2024, 17:58

Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI

Dana-Farber’s Breast Oncology Center shared a post on X:

“We are leading a phase 2 study, called TRUDI, to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and durvalumab) to learn if the intervention works in stage III, HER2-expressing Inflammatory Breast Cancer.”

Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI

Read further.

More featuring Dana-Farber’s Breast Oncology Center.

cancer Dana-Farber’s Breast Oncology Center Durvalumab inflammatory breast cancer OncoDaily Oncology Trastuzumab deruxtecan TRUDI
Special Coverage
Positive
Mar 30, 2025, 16:44
Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC
Blog
Mar 30, 2025, 16:43
Highlights from SSO25
Blog
Mar 30, 2025, 16:38
Embracing Palliative Care in Paediatric Oncology from Diagnosis Onwards course is now available on YouTube - SIOPE
Blog
Mar 30, 2025, 16:09
Hedley Lewis: No Family Should Face Childhood Cancer and Life-Threatening Blood Disorders Alone
Blog
Mar 30, 2025, 16:06
Anant Madabhushi: New Publication on AI-Driven Virtual Staining for Tumor-Associated Macrophages
Blog
Mar 30, 2025, 16:03
Research drives progress, and advocacy fuels change - Fight Colorectal Cancer
Blog
Mar 30, 2025, 15:52
St. Baldrick's Foundation - Honoring our heroes on National Doctors' Day
Blog
Mar 30, 2025, 15:48
Our experts are in Orlando for NCCN2025 - Roswell Park
Blog
Mar 30, 2025, 15:42
Peter Pisters: Honoring MD Anderson Cancer Center's Physicians on Doctors' Day for their commitment
Blog
Mar 30, 2025, 15:41
New NCI Funding Opportunity to New NCI Funding Opportunity to Address Cancer-Related Financial Hardship to Improve Patient Outcomes
Blog
Mar 30, 2025, 15:37
How PROs and CROs provide different but equally vital information - ESMO
Blog
Mar 30, 2025, 15:24
EORTC is Looking For a Medical Liaison Officer in Brussels